These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 10625052
1. Effect of 6-hydroxydopamine on neuropeptide Y and corticotropin-releasing factor expression in rat amygdala. Smiałowska M, Bajkowska M, Prezewłocka B, Maj M, Turchan J, Przewłocki R. Neuroscience; 1999; 94(4):1125-32. PubMed ID: 10625052 [Abstract] [Full Text] [Related]
2. Pharmacological studies on the monoaminergic influence on the synthesis and expression of neuropeptide Y and corticotropin releasing factor in rat brain amygdala. Smiałowska M, Bajkowska M, Heilig M, Obuchowicz E, Turchan J, Maj M, Przewłocki R. Neuropeptides; 2001 Apr; 35(2):82-91. PubMed ID: 11384203 [Abstract] [Full Text] [Related]
3. Alterations in corticotropin-releasing hormone gene expression of central amygdaloid neurons following long-term paraventricular lesions and adrenalectomy. Palkovits M, Young WS, Kovács K, Tóth Z, Makara GB. Neuroscience; 1998 Jul; 85(1):135-47. PubMed ID: 9607709 [Abstract] [Full Text] [Related]
4. Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: evidence for an allostatic shift? Caberlotto L, Rimondini R, Hansson A, Eriksson S, Heilig M. Neuropsychopharmacology; 2004 Jan; 29(1):15-22. PubMed ID: 12968131 [Abstract] [Full Text] [Related]
5. Neonatal thyroxine treatment: changes in the number of corticotropin-releasing-factor (CRF) and neuropeptide Y (NPY) containing neurons and density of tyrosine hydroxylase positive fibers (TH) in the amygdala correlate with anxiety-related behavior of wistar rats. Yilmazer-Hanke DM, Hantsch M, Hanke J, Schulz C, Faber-Zuschratter H, Schwegler H. Neuroscience; 2004 Jan; 124(2):283-97. PubMed ID: 14980379 [Abstract] [Full Text] [Related]
6. A 6-hydroxydopamine lesion of the mesostriatal dopamine system decreases the expression of corticotropin releasing hormone and neurotensin mRNAs in the amygdala and bed nucleus of the stria terminalis. Day HE, Vittoz NM, Oates MM, Badiani A, Watson SJ, Robinson TE, Akil H. Brain Res; 2002 Aug 02; 945(2):151-9. PubMed ID: 12126877 [Abstract] [Full Text] [Related]
7. Involvement of serotonergic pathways in mediating the neuronal activity and genetic transcription of neuroendocrine corticotropin-releasing factor in the brain of systemically endotoxin-challenged rats. Laflamme N, Feuvrier E, Richard D, Rivest S. Neuroscience; 1999 Jan 02; 88(1):223-40. PubMed ID: 10051203 [Abstract] [Full Text] [Related]
8. Vulnerability to nicotine abstinence-related social anxiety-like behavior: molecular correlates in neuropeptide Y, Y2 receptor and corticotropin releasing factor. Aydin C, Oztan O, Isgor C. Neurosci Lett; 2011 Mar 03; 490(3):220-5. PubMed ID: 21195134 [Abstract] [Full Text] [Related]
9. Localization of corticotropin-releasing hormone in the human locus coeruleus and pedunculopontine tegmental nucleus: an immunocytochemical and in situ hybridization study. Austin MC, Rice PM, Mann JJ, Arango V. Neuroscience; 1995 Feb 03; 64(3):713-27. PubMed ID: 7715783 [Abstract] [Full Text] [Related]
10. Reversal of the adaptive response of neuropeptide Y neurons in the rat striatum to nigrostriatal dopamine deafferentation by the N-methyl-D-aspartate antagonist dizocilpine maleate. Salin P, Nieoullon A, Kerkerian-Le Goff L. Neuroscience; 1994 Jul 03; 61(1):93-105. PubMed ID: 7969899 [Abstract] [Full Text] [Related]
11. Neuropeptide Y immunoreactivity and corticotropin-releasing hormone mRNA level are increased in the hypothalamus of mouse bearing a human oral squamous cell carcinoma. Lee JH, Cha MJ, Choi SH, Hwang SJ, Kim DG, Jahng JW. Neuropeptides; 2004 Dec 03; 38(6):345-50. PubMed ID: 15567470 [Abstract] [Full Text] [Related]
12. Neuropeptide Y Y5 receptor protein in the cortical/limbic system and brainstem of the rat: expression on gamma-aminobutyric acid and corticotropin-releasing hormone neurons. Grove KL, Campbell RE, Ffrench-Mullen JM, Cowley MA, Smith MS. Neuroscience; 2000 Dec 03; 100(4):731-40. PubMed ID: 11036207 [Abstract] [Full Text] [Related]
14. Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons. Kerkerian L, Salin P, Nieoullon A. Neuroscience; 1988 Sep 03; 26(3):809-17. PubMed ID: 3143926 [Abstract] [Full Text] [Related]
15. Elevated neuropeptide Y and corticotropin-releasing factor in the brain of a novel epileptic mutant rat: Noda epileptic rat. Jinde S, Masui A, Morinobu S, Takahashi Y, Tsunashima K, Noda A, Yamada N, Kato N. Brain Res; 1999 Jul 03; 833(2):286-90. PubMed ID: 10375706 [Abstract] [Full Text] [Related]
16. Coexistence of peptides (corticotropin releasing factor/neurotensin and substance P/somatostatin) in the bed nucleus of the stria terminalis and central amygdaloid nucleus of the rat. Shimada S, Inagaki S, Kubota Y, Ogawa N, Shibasaki T, Takagi H. Neuroscience; 1989 Jul 03; 30(2):377-83. PubMed ID: 2473417 [Abstract] [Full Text] [Related]
20. The effect of competitive and non-competitive NMDA receptor antagonists, ACPC and MK-801 on NPY and CRF-like immunoreactivity in the rat brain amygdala. Wierońska JM, Brański P, Pałvcha A, Smiałowska M. Neuropeptides; 2001 Jul 03; 35(5-6):219-26. PubMed ID: 12030805 [Abstract] [Full Text] [Related] Page: [Next] [New Search]